Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
CANbridge Pharmaceuticals Inc. ( (HK:1228) ) has shared an announcement.
CANbridge Pharmaceuticals Inc. has announced a trading halt on its shares on the Hong Kong Stock Exchange, effective from August 12, 2025. This halt is pending the release of an announcement containing inside information, which may have significant implications for the company’s operations and its stakeholders.
More about CANbridge Pharmaceuticals Inc.
CANbridge Pharmaceuticals Inc. is a biopharmaceutical company incorporated in the Cayman Islands, focusing on developing and commercializing innovative therapies for rare diseases and targeted cancers.
Average Trading Volume: 10,906,976
Technical Sentiment Signal: Buy
Current Market Cap: HK$573.5M
For a thorough assessment of 1228 stock, go to TipRanks’ Stock Analysis page.